Carlos A. Zarate, M.D.

Affiliations: 
National Institute of Mental Health, Bethesda, MD, United States 
Area:
Depression, Ketamine
Google:
"Carlos Zarate"
Mean distance: 16.18 (cluster 29)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Machado-Vieira R, Jones GH, Courtes AC, et al. (2024) The effect of intranasal (R,S)-ketamine on symptoms of fatigue in severe major depressive disorder or bipolar depression with and without comorbid alcohol use disorder: Results from a randomized, double-blind, placebo-controlled trial. Journal of Affective Disorders. 367: 281-285
Raja SM, Guptill JT, Mack M, et al. (2024) A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers. Clinical Pharmacology and Therapeutics
Johnston JN, Zarate CA, Kvarta MD. (2024) Esketamine in depression: putative biomarkers from clinical research. European Archives of Psychiatry and Clinical Neuroscience
Moses RG, Jodarski C, Setzer M, et al. (2024) Psychological state at the time of psychiatric genetic counseling impacts patient empowerment: A pre-post analysis. Journal of Genetic Counseling
Lee Y, Gilbert JR, Waldman L, et al. (2024) Potential association between suicide risk, aggression, impulsivity, and the somatosensory system. Social Cognitive and Affective Neuroscience
Jones GH, Vecera CM, Ruiz AC, et al. (2024) A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder. The Journal of Clinical Psychiatry. 85
Quintanilla B, Zarate CA, Pillai A. (2024) Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects? Molecular Psychiatry
Evans JW, Graves MC, Nugent AC, et al. (2024) Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers. Scientific Reports. 14: 4538
Ballard ED, Nischal RP, Burton CR, et al. (2024) Clinical and electrophysiological correlates of hopelessness in the context of suicide risk. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 80: 38-45
Fountoulakis KN, Tohen M, Zarate CA. (2024) Pharmacodynamic properties of lumateperone and its efficacy in acute bipolar depression: a mechanistic hypothesis based on data. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 81: 1-9
See more...